Perekliinik OÜ

14315115

Company info

Perekliinik OÜ

14315115

Perekliinik | Teie perearsthttp://www.perekliinik.eePerekliinik | Teie perearst

Perekliinik on kiiresti arenev, innovaatiline tervishoiuettevõte. Meie perearstikeskused asuvad Sõle ja Ülemiste Tervisemajas ning Kiili vallas.

General info

Name

Perekliinik OÜ

Registry code

14315115

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

21.08.2017 (7)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

69202 - Bookkeeping, tax consulting 70221 - Business and other management consultancy activities 68201 - Rental and operating of own or leased real estate 86211 - Provision of general medical treatment

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

-

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Ingmar Lindström

100% - 2 500.00 EUR Board member - Founder

Anna Melan

- Board member -

Marge Iidel

- Board member -

Related companies

Owner Representative Beneficial owner Roles

MTÜ Eesti Esmatasandi Tervisekeskuste Liit

80628250

- - - Founder (without contribution)

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q4 - 372 033.24 € 322 514.28 € 93
2024 Q3 - 300 802.45 € 319 714.83 € 94
2024 Q2 - 286 423.25 € 304 019.27 € 87
2024 Q1 - 267 316.69 € 282 171.05 € 93
2023 Q4 - 246 191.43 € 260 162.98 € 86
2023 Q3 - 226 027.37 € 235 428.08 € 81
2023 Q2 - 168 462.11 € 178 811.23 € 78
2023 Q1 - 140 368.58 € 149 065.78 € 74
2022 Q4 - 130 017.4 € 138 176.25 € 55
2022 Q3 - 124 766.26 € 132 507.09 € 57
2022 Q2 - 112 532.96 € 119 518.34 € 47
2022 Q1 - 106 329.46 € 113 005.86 € 50
2021 Q4 - 56 352.22 € 59 085.45 € 50
2021 Q3 - 20 804.95 € 21 219.76 € 42
2021 Q2 - 16 922.79 € 17 236.31 € 7
2021 Q1 - 19 082.97 € 19 440.93 € 7
2020 Q4 - 15 622.44 € 16 075.72 € 7
2020 Q3 - 35 393.38 € 29 591.1 € 7
2020 Q2 - 20 594.58 € 21 349.62 € 9
2020 Q1 - 21 634.27 € 22 788.18 € 9